## COO: The Cooper Companies, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 2.2% below STRENGTH zone (4.0-10.0%); PEG 2.15 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($73.27)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Cooper Companies initiates strategic review; shares jump**
- Source: WHBL News | 20251204T230811 | Bullish | Relevance: 100%
- Cooper Companies announced it is initiating a formal strategic review to enhance long-term shareholder value, causing its shares to jump 10% in extended trading. The medical device maker has been under activist pressure from firms like Browning West and JANA Partners to improve operations and capital allocation. Cooper also forecast fiscal 2026 profit above Wall Street expectations, banking on cost savings and strong contact lens demand.

**2. CooperCompanies (NASDAQ:COO) Reports Q3 CY2025 In Line With Expectations, Stock Soars**
- Source: Finviz | 20251204T220936 | Bullish | Relevance: 100%
- CooperCompanies (NASDAQ:COO) reported Q3 CY2025 revenue of $1.07 billion, meeting Wall Street expectations with 4.6% year-on-year sales growth. The company's non-GAAP profit was $1.15 per share, exceeding analyst estimates by 3.2%. Management provided optimistic guidance for Q4 CY2025 and fiscal year 2026, leading to a 5% stock increase immediately after the results.

**3. Cooper Companies stock soars after strategic review announcement**
- Source: Investing.com | 20251204T220805 | Bullish | Relevance: 100%
- Cooper Companies Inc (NASDAQ:COO) stock surged 11.3% after announcing a comprehensive strategic review and reporting better-than-expected fiscal fourth-quarter and full-year 2025 results. The review aims to enhance shareholder value through various transactions, and the company also initiated optimistic fiscal 2026 guidance.

**4. CooperCompanies (NASDAQ:COO) Reports Q3 CY2025 In Line With Expectations, Stock Soars**
- Source: Markets Financial Content | 20251204T220732 | Bullish | Relevance: 100%
- CooperCompanies (NASDAQ: COO) met Q3 CY2025 revenue expectations with sales up 4.6% to $1.07 billion, and non-GAAP profit exceeded analyst estimates by 3.2%. The company provided positive revenue and EPS guidance for the upcoming quarters and fiscal year 2026, leading to a 5% stock increase immediately following the results. CooperCompanies' historical growth in sales and EPS, coupled with efficient operating margins, suggests a solid financial standing despite a slight recent slowdown in revenue growth.

**5. Cooper Companies initiates strategic review; shares jump**
- Source: TradingView | 20251204T213737 | Bullish | Relevance: 100%
- Cooper Companies (COO) announced it is undertaking a formal strategic review to enhance long-term shareholder value, causing its shares to surge 11.7% in extended trading. This move follows reports that activist investor Jana Partners had built a stake in the company and planned to push for strategic alternatives. The review will focus on improving performance, expanding market share, enhancing operational efficiency, and disciplined capital deployment.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-13 | Wells Fargo | $72 | $72 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-13 | Wells Fargo | down | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 7 ($0.91M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.2% (-1.1%)
- Blackrock Inc.: 7.8% (-0.8%)
- Capital World Invest: 5.4% (+25.7%)
- T. Rowe Price Invest: 5.0% (+33.2%)
- State Street Corpora: 4.4% (-0.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.15 elevated, pricing in significant growth expectations. Insider buying signal ($0.9M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $16.4B |
| Beta | 1.05 |
| 52W Range | $61.78 - $100.24 |
| Short Interest | 3.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.15 |
| Forward P/E | 15.6 |
| Current P/E | 17.1 |
| YoY Growth | 9.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 6.2% to 2.2% (-4.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.8pp (needs >4.0% for momentum thesis). MRS_5 (-0.2%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 4.3% shows strong absolute momentum above own 20MA. Outperforming sector by 3.6pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). Elevated volume (1.6x 20MA), institutional activity likely. OFD pattern: +MUH (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.17% (CS: 70) | Neutral |
| RSI_14 | 63.1 | Neutral |
| MACD Histogram | 0.25 | Bullish |
| vs SMA20 | 1.043x | Above |
| vs SMA50 | 1.073x | Above |
| vs SMA200 | 1.028x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $77.03
- **Stop Loss:** $73.27 (4.9% risk)
- **Target:** $80.79 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 132
- **Position Value:** $10,167.96
- **Portfolio %:** 10.17%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-03-05 (Est: $1.03)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $1.11 | $1.15 | +3.3% |
| 2025Q3 | $1.07 | $1.10 | +3.0% |
| 2025Q2 | $0.93 | $0.96 | +3.3% |
| 2025Q1 | $0.91 | $0.92 | +0.9% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*